NZ510376A - Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers - Google Patents

Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers

Info

Publication number
NZ510376A
NZ510376A NZ510376A NZ51037699A NZ510376A NZ 510376 A NZ510376 A NZ 510376A NZ 510376 A NZ510376 A NZ 510376A NZ 51037699 A NZ51037699 A NZ 51037699A NZ 510376 A NZ510376 A NZ 510376A
Authority
NZ
New Zealand
Prior art keywords
inhibition
dendrimers
polyamines
proteins
substances
Prior art date
Application number
NZ510376A
Inventor
George Holan
Karen Wendy Mardell
Barry Ross Matthews
Original Assignee
Starpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Starpharma Ltd filed Critical Starpharma Ltd
Publication of NZ510376A publication Critical patent/NZ510376A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Abstract

Described is the use in the manufacture of a medicament for prophylactic or therapeutic inhibition of a toxic material or substance in a human or non-human animal patient, a dendrimer having a plurality of terminal groups wherein at least one of the terminal groups has an anionic- or cationic-containing moiety bonded or linked thereto.
NZ510376A 1998-09-14 1999-09-13 Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers NZ510376A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5843A AUPP584398A0 (en) 1998-09-14 1998-09-14 Inhibition of toxic materials or substances
PCT/AU1999/000762 WO2000015239A1 (en) 1998-09-14 1999-09-13 Inhibition of toxic materials or substances using dendrimers

Publications (1)

Publication Number Publication Date
NZ510376A true NZ510376A (en) 2002-10-25

Family

ID=3810065

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510376A NZ510376A (en) 1998-09-14 1999-09-13 Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers

Country Status (9)

Country Link
EP (1) EP1113805A4 (en)
JP (1) JP2002524523A (en)
KR (1) KR20010075089A (en)
CN (1) CN1323215A (en)
AU (1) AUPP584398A0 (en)
BR (1) BR9913718A (en)
CA (1) CA2343205A1 (en)
NZ (1) NZ510376A (en)
WO (1) WO2000015239A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720355B2 (en) 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
AUPP584298A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Antimicrobial and antiparasitic agents
EP1187622A4 (en) * 1999-06-01 2005-06-22 Univ California Method of sterilizing
KR100413532B1 (en) * 2001-02-14 2003-12-31 학교법인 포항공과대학교 Polyamine terminated dendrimers and preparing method thereof
AUPR412801A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agent for the prevention and treatment of sexually transmitted disease s - I
AUPR412901A0 (en) * 2001-03-30 2001-05-03 Starpharma Limited Agents for the prevention and treatment of sexually transmitted disease s - II
WO2004072153A1 (en) * 2003-02-13 2004-08-26 National Center For Scientific Research 'demokritos' Multifunctional dendrimers and hyperbranched polymers as drug and gene delivery systems
CN1296711C (en) * 2004-05-14 2007-01-24 沈阳迈迪生物医学技术有限公司 Breast cancer Her-2 immunohisto chemical diagnostic kit
CN101365462A (en) 2005-10-18 2009-02-11 星药股份有限公司 Microbicidal dendrimer composition delivery system
EP1981512B1 (en) 2006-01-20 2022-11-02 Starpharma Pty Limited Modified macromolecule
EP1996209B1 (en) 2006-03-22 2015-11-04 Starpharma Pty Limited Contraceptive composition
JP4949206B2 (en) * 2007-11-09 2012-06-06 独立行政法人科学技術振興機構 Polyion dendrimers for biomolecular modification
JP4767295B2 (en) * 2008-07-17 2011-09-07 独立行政法人科学技術振興機構 Cytochrome c capture type apoptosis inhibitor
CN102743411A (en) * 2012-07-25 2012-10-24 中国人民解放军第四军医大学 Application of polyamide dendritic large molecule to preparation of medicament for preventing or treating septicopyemia
CN105524285B (en) * 2014-10-21 2018-06-15 浙江大学 Dendritic macromole containing thiocarbamide and dissaving polymer containing thiocarbamide and its preparation method and application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5914095A (en) * 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
JPH10501665A (en) * 1994-06-15 1998-02-10 フィリップス エレクトロニクス ネムローゼ フェンノートシャップ Differential amplifier with common mode rejection for low supply voltage

Also Published As

Publication number Publication date
WO2000015239A1 (en) 2000-03-23
CA2343205A1 (en) 2000-03-23
EP1113805A1 (en) 2001-07-11
KR20010075089A (en) 2001-08-09
JP2002524523A (en) 2002-08-06
CN1323215A (en) 2001-11-21
EP1113805A4 (en) 2004-05-19
BR9913718A (en) 2001-05-29
AUPP584398A0 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
NZ510376A (en) Inhibition of toxic materials or substances, including peptides, proteins and polyamines, using dendrimers
DK1093383T3 (en) Drug delivery system comprising a homeobox peptide and a cytotoxic or antineoplastic drug
FI962154A0 (en) Composition for in vivo preparation of therapeutic products
DE69807634D1 (en) MEDICAL DEVICE FOR THE ADMINISTRATION OF THERAPEUTIC ACTIVE SUBSTANCES
ATE318590T1 (en) DRUG COMBINATIONS (E.G. CHLORPROMAZINE AND PENTAMIDINE) FOR THE THERAPY OF NEOPLASTIC DISEASES
DE69832298D1 (en) DEVICE FOR THE CONTROLLED DELIVERY OF PHARMACEUTICAL AND MEDICAL PRODUCTS
FR2792202B1 (en) LUPINE PEPTIDE EXTRACT AND PHARMACEUTICAL OR COSMETIC OR NUTRACEUTICAL COMPOSITION COMPRISING SUCH EXTRACT
EP0887075A3 (en) Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE69526516T2 (en) DEVICE FOR ADMINISTERING PEPTIDE ACTIVE SUBSTANCES IN AEROSOL FORM
DE122007000002I1 (en) A pharmaceutical preparation for use in the treatment of diabetes.
DE59009462D1 (en) Implantable device for the metered delivery of medication into the human body.
SE9704546D0 (en) Novel compounds
ATE338771T1 (en) ANTAGONISTS OF THE INTESTINOTROPH GLP-2 PEPTIDE
ATE231717T1 (en) IMPLANTS WITH PHASE-WISE MEDICINAL DELIVERY
DE69628162D1 (en) POLYMER MATERIAL, MEDICAL MATERIAL AND LIQUID POLYMER COMPOSITION
NZ292565A (en) Production of stabilised complement protein-3 convertase
RU96116802A (en) DRESSING
DE59609508D1 (en) CONJUGATE CONTAINING DTPA AND ALBUMIN FOR THE INDIVIDUAL DOSAGE OF MEDICINAL PRODUCTS
DE50003454D1 (en) PROTEIN CONTAINING PHARMACEUTICAL PREPARATION
ATE302210T1 (en) HISTOGRANIN PEPTIDES AND THEIR ANALGESIC USE
DE69939075D1 (en) Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus
DE69910809D1 (en) Use of OmpA enterobacter proteins to target antigen-presenting cells
KR100488038B1 (en) New bpc peptide salts with organo-protective activity the process for their preparation and their use in therapy
DE59607949D1 (en) SOLID MEDICINAL FORM WITH POLYMER MATERIAL DISTRIBUTED ACTIVE SUBSTANCE
NL1000332C1 (en) Gradual chemical modification of biologically active peptides and proteins.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)